This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bosso, J. A.
Right arrow Articles by Mauldin, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bosso, J. A.
Right arrow Articles by Mauldin, P. D.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2006, p. 2106-2112, Vol. 50, No. 6
0066-4804/06/$08.00+0     doi:10.1128/AAC.01359-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Using Interrupted Time Series Analysis To Assess Associations of Fluoroquinolone Formulary Changes with Susceptibility of Gram-Negative Pathogens and Isolation Rates of Methicillin-Resistant Staphylococcus aureus

John A. Bosso1,2* and Patrick D. Mauldin1,3,4

Department of Pharmacy and Clinical Sciences, South Carolina College of Pharmacy,1 Department of Medicine, College of Medicine, Medical University of South Carolina,2 Center for Medication Safety, South Carolina College of Pharmacy,3 Ralph H. Johnson VA Medical Center, Charleston, South Carolina4

Received 18 October 2005/ Returned for modification 21 December 2005/ Accepted 6 April 2006

The use of fluoroquinolones has been linked to increasing bacterial resistance and infection and/or colonization with already resistant pathogens both as a risk factor and based on volume of use. Changes in individual fluoroquinolones used in an institution may also be related to these clinical problems. Interrupted time series analysis, which allows for assessment of the associations of an outcome attributable to a specific event in time, was used to study the effect of changes in our hospital's fluoroquinolone formulary on fluoroquinolone susceptibility rates in select gram-negative pathogens and the methicillin-resistant Staphylococcus aureus (MRSA) isolation rate. Susceptibility rates to ciprofloxacin were considered for the period of 1993 through 2004, while the MRSA isolation rate was assessed from 1995 through 2004. Levofloxacin was added to the formulary in 1999, and gatifloxacin was substituted for levofloxacin in 2001. Statistically significant changes in the already declining rates of susceptibility of Pseudomonas aeruginosa (P, 0.042) and Escherichia coli (P, 0.004) to ciprofloxacin and in the already rising MRSA isolation rate (P, 0.001) were associated with the addition of levofloxacin to the formulary. Substitution of gatifloxacin for levofloxacin on the formulary was associated with reversals in the downward trend in E. coli susceptibility to ciprofloxacin and the upward trend in MRSA isolation rate. No associations were detected on susceptibility of Klebsiella pneumoniae or Proteus mirabilis to ciprofloxacin. These findings suggest that potential changes in susceptibility to fluoroquinolones and isolation of MRSA may vary by both drug and organism.

* Corresponding author. Mailing address: Department of Pharmacy and Clinical Sciences, South Carolina College of Pharmacy, P.O. Box 250140, Charleston, SC 29425. Phone: (843) 792-8501. Fax: (843) 792-1712. E-mail: bossoja{at}musc.edu.

Antimicrobial Agents and Chemotherapy, June 2006, p. 2106-2112, Vol. 50, No. 6
0066-4804/06/$08.00+0     doi:10.1128/AAC.01359-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Vernaz, N., Sax, H., Pittet, D., Bonnabry, P., Schrenzel, J., Harbarth, S. (2008). Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. J Antimicrob Chemother 62: 601-607 [Abstract] [Full Text]  
  • Harbarth, S., Samore, M. H. (2008). Interventions to control MRSA: high time for time-series analysis?. J Antimicrob Chemother 62: 431-433 [Abstract] [Full Text]  
  • Gould, I. M. (2008). Antibiotic policies to control hospital-acquired infection. J Antimicrob Chemother 61: 763-765 [Abstract] [Full Text]  
  • Mauldin, P. D, Salgado, C. D, Durkalski, V. L, Bosso, J. A (2008). Nosocomial Infections Due to Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: Relationships with Antibiotic Use and Cost Drivers. The Annals of Pharmacotherapy 42: 317-326 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»